Diane DiEuliis, Peter Emanuel, James Giordano and Alexander Titus
A common expression heard in the military is, “we are always fighting the last war.” In the face of global response to the COVID-19 crisis, the “last war” was the influenza pandemic of 1918.
Although history provides invaluable lessons, it is vital to re-contextualize the issues, problems and solutions of the past in light of the circumstances, capabilities and complexities of the present. The COVID-19 pandemic has generated a dilemma of ensuring public safety and health, while simultaneously attempting to stabilize and sustain the economy.
Meanwhile, demonstrably beneficial, available advanced technologies are not being fully utilized to maximize ethically sound, effective and efficient approaches to reducing the pandemic burden and its effects. If there was ever a time to put such tools to use, it is now. (Full Article)
Vision Systems Design
For drug formulation, development, manufacturing and shelf stability, the type, size and quantity of particulate matter present in injectable drugs affects the drug’s efficacy. In some cases, such non-soluble particles may also present a potential safety risk. Understanding the nature of these particles is critical to ensuring the drug products work as intended and do so without causing adverse events.
“Until recently, even the most advanced technology available had trouble detecting and counting particles smaller than 10 microns,” says Kent Peterson, CEO, Fluid Imaging Technologies (Scarborough, ME, USA; www.fluidimaging.com). “Lacking the technological ability to do so, it becomes easier to understand why many pharmaceutical scientists drew the line of concern at 10 microns and larger.” (Full Article)
Learn how UnitedPros can help you with advanced vision and imaging systems for Biotechnology and Pharmaceuticals.